Disease: Carcinoma breast stage IV ×
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Carcinoma breast stage IV
CUI: C0278488
Disease: Carcinoma breast stage IV
0.010 GeneticVariation BEFREE Although HER2-unamplified MBC patients do not regularly benefit from anti-HER2 target therapy, HER2 V777L mutation detected by next-generation sequencing from ctDNA may present as a predictive biomarker for anti-HER2-based strategy therapy in HER2-negative MBC patients. 31118664 2019